United States News Todas as matérias

Nissan and Honda (NYSE:HMC) agreed to jointly develop vehicle computer parts and software for models planned to enter the market in fiscal 2029, with the companies sharing core electronic control units and software.

Alvotech (NASDAQ:ALVO) announced that the U.S. Food and Drug Administration accepted its Biologics License Application for AVT80, a proposed interchangeable biosimilar to Entyvio (vedolizumab) in prefilled syringe and autoinjector formats.

Brent crude futures rose 2% to $89.87 per barrel and U.S. West Texas Intermediate crude increased 1.74% to $84.85 after U.S. strikes on Iran’s Larak Island intensified concerns about energy flows through the Strait of Hormuz.

BioMarin (NASDAQ:BMRN) entered into binding global settlement terms with Ascendis Pharma A/S to resolve patent disputes involving Yuviwel, including a U.S. International Trade Commission investigation and litigation in multiple countries.

Amgen (NASDAQ:AMGN) reported Phase 3 VESALIUS-CV trial results showing Repatha reduced the risk of death by 20% among more than 12,000 high-risk adults without previous heart attack or stroke over a median 4.6-year follow-up.

LexinFintech Holdings (NASDAQ:LX) reported second quarter 2026 operating revenue of RMB3,187 million, down 11.2% year over year, while net income attributable to ordinary shareholders fell 80.2% to RMB101 million.

• SpaceX announced plans to launch Nvidia-powered AI satellite systems in Q4 2027, advancing its previous target for initial orbital data center deployments.
• The project combines SpaceX launch infrastructure with Nvidia Vera Rubin computing systems designed for AI workloads in orbit.
• The broader AI infrastructure market is expanding as semiconductor firms, cloud providers, and data center operators invest in higher computing capacity.

• DICK’S Sporting Goods (NYSE:DKS) reported Q2 2026 sales of $5.59 billion, up 53.2% year over year, after incorporating the Foot Locker acquisition into results.
• The company’s operating margin declined to 7.9% from 12.4%, while GAAP EPS fell to $3.50 as Foot Locker reported weaker performance and pressured profitability.
• The broader athletic retail sector faces pressure from changing footwear demand, inventory levels, and companies’ strategies to adjust product mixes and margins. 

Better Home & Finance Holding Company (NASDAQ:BETR) urged shareholders to reject former CEO Vishal Garg’s consent solicitation campaign, which seeks to remove five board members and install replacement directors.

Amarin (NASDAQ:AMRN) reported new post hoc REDUCE-IT Legacy analysis data showing that patients with high adherence to icosapent ethyl experienced an approximately 29%–30% relative reduction in the primary cardiovascular endpoint compared with placebo.

SuperX AI Technology (NASDAQ:SUPX) announced that subsidiary SuperX Microinference signed a long-term equipment and services supply agreement with Australian compute provider Ezisight for 128 B300 AI server clusters.

Best Buy (NYSE:BBY) announced that its Board of Directors authorized a regular quarterly cash dividend of $0.96 per common share, with payment scheduled for October 8, 2026.

Chagee Holdings (NASDAQ:CHA) reported second-quarter 2026 net revenue of RMB3,414.6 million (US$503.3 million), up 2.5% year over year from RMB3,331.9 million.

Gap (NYSE:GAP) lowered its full-year 2026 net sales growth forecast after Old Navy reported weaker-than-expected second-quarter results, with company revenue declining 2% to $3.65 billion.

United Therapeutics (NASDAQ:UTHR) announced eight presentations at the 2026 European Society of Cardiology and European Respiratory Society congresses covering investigational therapies for pulmonary arterial hypertension and other lung diseases.

iBio (NASDAQ:IBIO) reported fiscal 2026 results as it advanced into clinical-stage development, with its Phase 1 trial of IBIO-600 progressing after 31 of 32 participants were dosed across four cohorts.

Eli Lilly (NYSE:LLY) received U.S. FDA approval for an expanded indication of Mounjaro (tirzepatide) to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes at high cardiovascular risk.

Altria Group (NYSE:MO) appointed Steven W. Presley to its Board of Directors effective August 27, 2026, adding a director with experience in food and beverage operations.

Caleres (NYSE:CAL) announced that its Board of Directors declared a regular quarterly cash dividend of $0.07 per share, payable on September 25, 2026.

Dollar General (NYSE:DG) announced that Executive Vice President and General Counsel Rhonda Taylor will retire from the company, with Kelly Collier appointed as her successor effective December 7, 2026.

Range Resources (NYSE:RRC) announced that its Board of Directors declared a third-quarter 2026 quarterly cash dividend of $0.10 per common share.

Jiayin Group (NASDAQ:JFIN) reported second-quarter 2026 net revenue of RMB736.9 million, down 60.9% year over year, as transaction volume declined to RMB9.5 billion from the prior-year period.

Quoin Pharmaceuticals (NASDAQ:QNRX) reported positive interim results from its Phase 2/3 CL-QRX003-004 study showing QRX003 4% lotion met its primary endpoint in the first six participants with Netherton Syndrome.

MINISO Group (NYSE:MNSO) reported first-half 2026 revenue of RMB11,498.9 million, up 22.4% year over year, as gross profit increased to RMB5,093.7 million and its global store network expanded.